Tryptamine Therapeutics completes phase 1b of IV-infused psilocin trial

By Proactive Investors / August 26, 2024 / www.youtube.com / Article Link

Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) CEO Jason Carroll joins Proactive's Tylah Tully to discuss the completion of ...

Recent News

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com

Gold stocks down with GDXJ outperforming on rebalancing

September 21, 2026 / www.canadianminingreport.com

Copper slides as US apparently wavering on tariff hikes

September 14, 2026 / www.canadianminingreport.com

Historically huge distortion in global copper inventory balance

September 14, 2026 / www.canadianminingreport.com

Gold stocks pause along with metal price

September 07, 2026 / www.canadianminingreport.com

See all >